Agrinos : Fourth Quarter and Full Year 2015 Interim Report

« Return to News

Highlights

• Q4 Sales Revenue increased to USD 2.97 million vs. USD 1.47 million in Q4 2014
• FY 2015 sales revenue of USD 6.43 million vs. USD 6.28 million in FY2014
• Announced intention for Strategic Partnership Agreements with EuroChem Group AG
• Announced construction of a State-of-the-Art Microbial Crop Input Production Facility in Oregon
• Distribution of Microbial Crop Solutions premixed with UAN at Security Seed & Chemical's New Fertilizer terminal in Kentucky
• Distribution agreements with Rallis, ButtonWillow Warehouse Company, and partnerships with Zuari Agri Sciences and PT Sampoerna Agro.
• Steve Sinkula, VP Business Development, Terry Stone, VP of Regulatory Affairs and Sustainability Programs, Bruce Odens VP North America Business, and Dr. Michael Austin, Head of Global Agronomy, join Agrinos
• Camilla Nilsson appointed as VP Europe, Middle East and Central Asia businesses, and Indranil Das appointed as VP Asia and India businesses
• Matthieu Baumgartner and Svetoslav Valkov appointed to the Board of Directors

'Our long-term strategy of focusing on core markets, building experienced corporate management and business leadership teams, and developing world-class Global Research & Development and Production & Operations capabilities, has seen significant progress in 2015. Initiated in 2014, Agrinos has now completed the reorganization and build-out of our corporate management, business leadership, research & development and production & operations teams. We continued to expand our research and development efforts to deliver highly effective biological crop nutrition solutions to the market today and in the future. Agrinos also announced our intention to open a new Microbial Crop Input Production facility in Oregon to meet current and future production demands, ensure continued quality of HYT® products, and support the commercialization of new product offerings. To drive future sales growth, Agrinos developed several exciting new commercial distribution partnerships, including the strategic partnership EuroChem Group AG and their affiliate EuroChem Agro (EuroChem) that was announced in January 2016.' said Chief Executive Officer, D. Ry Wagner.

'Agrinos has also filled several critical leadership positions to enhance Agrinos' management team. Our talented and experienced leadership team will continue develop our partner-based commercial distribution network and solidify Global Research & Development along with Global Regulatory & Sustainability. The company also strengthened its financial, business development and technology representation on the Board of Directors with the appointment of Matthieu Baumgartner and Svetoslav Valkov.'

'In the midst of a challenging year for multinational agricultural-related businesses due to low commodity crop prices coupled with currency effects, Agrinos is making excellent progress in developing its core businesses and product-pipeline capabilities to ensure both the near-term and long-term growth. In spite industry-related challenges, Agrinos has realized growth in revenue versus the same period last year in our newer core geographies which is a strong indicator that Agrinos partnerships and products are gaining the traction in the key market segments required to fuel long-term growth. The Company has made these accomplishments with a total operating expense which was less than that of the same period for 2014, even with the inclusion of significant one-time charges in 2015, and while retaining a strong and stable employee base. Agrinos employees around the world have maintained a strong focus on cost control while increasing our core strengths and ability to deliver on Agrinos' long-term vision.

Having now completed the reorganization of the company, I am very excited about the future of Agrinos as we continue to implement our growth strategy. This strategy was further enhanced and validated by the conclusion of a Private Placement investment by EuroChem and our strategic investors, Manor Investment SA and Havfonn AS, and our Research and Development and Sales and Marketing partnership with EuroChem, all of which were announced in January 2016. The partnership with EuroChem aligns perfectly with our growth plans for Agrinos, and the private placement has provided the financial resources to continue on a stable path to achieve our growth ambitions for the future.' Wagner concluded.

Material

Agrinos' interim report is available from the company's website www.agrinos.com.

For further information, please contact:
John Janczak, CFO
Mobile: [phone]
E-mail: [e-mail]

About Agrinos

Agrinos is a biological crop input provider committed to improving the productivity and sustainability of modern agriculture. Agrinos' range of High Yield Technology® ('HYT®') products helps farmers to practice profitable agriculture by providing increased crop productivity, improved efficiency of conventional fertilizer and a reduced environmental footprint.

Certified as organic and based on Agrinos' proprietary technology, the HYT® products provide benefits by strengthening the soil-based microbial ecosystem, stimulating crop development at key points in the growth cycle and boosting natural plant resistance to pathogens and threats. With solutions for a variety of crop categories, the technology comprising the HYT® products has demonstrated its value in third-party trials in key agricultural regions worldwide.

Cautionary statement on forward-looking statements

This document contains certain forward-looking statements relating to the business, financial performance and results of the company and/or the industry in which it operates. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words 'believes', expects', 'predicts', 'intends', 'projects', 'plans', 'estimates', 'aims', 'foresees', 'anticipates', 'targets', and similar expressions. The forward-looking statements contained in this announcement, including assumptions, opinions and views of the company or cited from third party sources are solely opinions and forecasts which are subject to risks, uncertainties and other factors that may cause actual events to differ materially from any anticipated development. Neither the company, nor any of its parent or subsidiary undertakings or any such person's officers or employees provides any assurance that the assumptions underlying such forward-looking statements are free from errors nor does any of them accept any responsibility for the future accuracy of the opinions expressed in this announcement or the actual occurrence of the forecasted developments. No obligation, except as required by law, is assumed to update any forward-looking statements or to conform these forward-looking statements to our actual results.

« Return to News